Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
EGFR MasterKey inhibitor
DRUG CLASS:
EGFR MasterKey inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
BDTX-1535 (4)
BDTX-1535 (4)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
BDTX-1535
Sensitive: C3 – Early Trials
BDTX-1535
Sensitive
:
C3
BDTX-1535
Sensitive: C3 – Early Trials
BDTX-1535
Sensitive
:
C3
EGFR mutation
Glioblastoma
EGFR mutation
Glioblastoma
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
EGFR amplification
Non Small Cell Lung Cancer
EGFR amplification
Non Small Cell Lung Cancer
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
EGFR amplification
Glioblastoma
EGFR amplification
Glioblastoma
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
BDTX-1535
Sensitive: D – Preclinical
BDTX-1535
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login